Dipna Pharmachem Ltd: Intrinsic Value & Share Price Analysis

Q: What is the current share price and 52-week range of Dipna Pharmachem Ltd?

Dipna Pharmachem Ltd is trading at 9.25 as of 21 April 2026, with a FY2026-2027 high of 26.3 and low of 7.45. The stock is currently near its 52-week low. Market cap stands at 24.3 Cr..

Q: Is Dipna Pharmachem Ltd financially healthy?

Key indicators: ROCE of 6.64 % is on the lower side. Dividend yield is 0.00 %.

Q: Is Dipna Pharmachem Ltd profitable and how is the profit trend?

Dipna Pharmachem Ltd reported a net profit of 1 Cr in Mar 2025 on revenue of 125 Cr. Compared to 1 Cr in Mar 2022, the net profit shows a mixed trend.

Fair Value

₹6.07Overvalued by 34.38%vs CMP ₹9.25

P/E (11.9) × ROE (2.6%) × BV (₹24.50) × DY (2.00%)

₹13.18Undervalued by 42.49%vs CMP ₹9.25

MoS: +29.8% (Adequate)Confidence: 43/100 (Low)Models: 4 Under, 2 Fair, 2 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹2.27	26%	Over (-75.5%)
Graham Number	Earnings	₹21.77	18%	Under (+135.4%)
DCF	Cash Flow	₹2.18	15%	Over (-76.4%)
Net Asset Value	Assets	₹22.46	8%	Under (+142.8%)
EV/EBITDA	Enterprise	₹9.90	10%	Fair (+7%)
Earnings Yield	Earnings	₹8.60	8%	Fair (-7%)
ROCE Capital	Returns	₹22.18	8%	Under (+139.8%)
Revenue Multiple	Revenue	₹47.58	6%	Under (+414.4%)
Consensus (8 models)		₹13.18	100%	Undervalued

Key Drivers: EPS CAGR -62.6% drags value — could be higher if earnings stabilize. | ROE 2.6% is below cost of equity.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -62.6%

*Investments are subject to market risks

Analyst Summary

Dipna Pharmachem Ltd operates in the Pharmaceuticals segment, NSE: DPL | BSE: 543594, current market price is ₹9.25, market cap is 24.3 Cr.. At a glance, stock P/E is 11.9, ROE is 2.55 %, ROCE is 6.64 %, book value is 24.5, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹13.18, which is about 42.5% above the current price, so the page currently reads as potentially undervalued rather than fully priced. On operating trend, latest reported sales are about ₹125 Cr versus the prior period change of -23.8%, while latest net profit is about ₹1 Cr with a prior-period change of 0.0%. The 52-week range shown on this page is 26.3/7.45, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisDipna Pharmachem Ltd. is a Public Limited Listed company incorporated on 19/07/2011 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L241…

This summary is generated from the stock page data available for Dipna Pharmachem Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

Dipna Pharmachem Ltd scores 44/100 (Weak)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health42/100 · Moderate

ROCE 6.6% WeakROE 2.6% WeakD/E 21.74 High debtInterest Coverage 0.0x RiskyProfitable 4/5 years Consistent

Smart Money50/100 · Moderate

Promoter holding at 9.1% Stable

Earnings Quality40/100 · Moderate

OPM stable around 3% SteadyWorking capital: 137 days Capital intensive

Quarterly Momentum50/100 · Moderate

Revenue (4Q): +20% YoY GrowingProfit (4Q): -33% YoY Declining

Industry Rank45/100 · Moderate

P/E 11.9 vs industry 53.8 Cheaper than peersROCE 6.6% vs industry 16.4% Below peersROE 2.6% vs industry 15.2% Below peers3Y sales CAGR: 20% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:29 am

Market Cap	24.3 Cr.
Current Price	9.25
Intrinsic Value	₹13.18
High / Low	26.3/7.45
Stock P/E	11.9
Book Value	24.5
Dividend Yield	0.00 %
ROCE	6.64 %
ROE	2.55 %
Face Value	10.0
PEG Ratio	-0.19

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Dipna Pharmachem Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gennex Laboratories Ltd	208 Cr.	8.55	17.2/7.05	11.9	8.79	0.00 %	13.0 %	10.2 %	1.00
Dipna Pharmachem Ltd	24.3 Cr.	9.25	26.3/7.45	11.9	24.5	0.00 %	6.64 %	2.55 %	10.0
Colinz Laboratories Ltd	5.79 Cr.	46.0	87.9/36.1	11.8	39.2	0.00 %	6.72 %	5.43 %	10.0
Checkpoint Trends Ltd	25.0 Cr.	45.8	144/14.7	12.2	3.60	0.00 %	16.5 %	9.17 %	10.0
Natco Pharma Ltd	17,945 Cr.	1,002	1,060/660	11.5	483	0.60 %	32.8 %	28.0 %	2.00
Industry Average	19,815.15 Cr	1,053.84		53.84	201.20	0.39%	16.35%	15.16%	6.10

All Competitor Stocks of Dipna Pharmachem Ltd

Quarterly Result

Metric	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025
Sales	29	44	49	74	74	90	91	34	74
Expenses	28	42	48	73	73	88	89	32	71
Operating Profit	1	1	1	2	2	2	1	2	3
OPM %	3%	3%	2%	2%	2%	2%	2%	6%	4%
Other Income	-0	0	-0	-0	-0	-0	-0	-0	-0
Interest	0	0	0	1	1	1	1	1	1
Depreciation	-0	-0	-0	0	0	0	-0	0	0
Profit before tax	0	1	0	1	1	1	0	1	2
Tax %	25%	26%	26%	27%	27%	21%	26%	34%	26%
Net Profit	0	1	0	1	1	0	0	1	1
EPS in Rs	33.00	84.00	0.13	0.24	0.24	0.20	0.14	0.27	0.59

Last Updated: February 2, 2026, 6:46 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 3:50 am

Metric	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	17	20	30	31	73	100	164	125	108
Expenses	16	20	30	31	71	98	161	121	103
Operating Profit	0	0	0	0	2	2	3	4	5
OPM %	2%	2%	1%	1%	3%	2%	2%	3%	5%
Other Income	0	0	0	0	0	0	0	0	0
Interest	0	0	0	0	1	1	2	2	2
Depreciation	0	0	0	0	0	0	0	0	0
Profit before tax	0	0	0	0	2	1	1	1	3
Tax %	14%	40%	0%	60%	26%	34%	24%	32%
Net Profit	0	0	0	0	1	1	1	1	2
EPS in Rs	6.00	3.00	6.00	2.00	117.00	0.37	0.45	0.40	0.86
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	0.00%	0.00%	0.00%
Change in YoY Net Profit Growth (%)	0.00%	0.00%	0.00%

Dipna Pharmachem Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 3 years from 2022-2023 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	33%
3 Years:	20%
TTM:	-24%

Compounded Profit Growth
10 Years:	%
5 Years:	74%
3 Years:	-6%
TTM:	-11%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	142%

Return on Equity
10 Years:	%
5 Years:	5%
3 Years:	4%
Last Year:	3%

Last Updated: September 5, 2025, 3:16 pm

Balance Sheet

Last Updated: March 3, 2026, 2:51 am

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	0.04	0.04	0.04	0.04	0.04	12	24	24	24
Reserves	0	0	1	1	2	12	13	14	35
Borrowings	5	6	10	12	10	16	19	17	14
Other Liabilities	6	8	8	12	24	37	76	77	105
Total Liabilities	11	14	18	25	36	78	133	132	177
Fixed Assets	0	0	0	0	0	0	0	0	0
CWIP	-0	-0	-0	-0	-0	-0	-0	-0	-0
Investments	-0	-0	-0	-0	-0	-0	-0	-0	-0
Other Assets	11	14	18	25	36	78	133	132	177
Total Assets	11	14	18	25	36	78	133	132	177

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	-3	-2	3	-21	-5	-9
Cash from Investing Activity +	0	0	-0	-0	-0	-0
Cash from Financing Activity +	3	2	-3	26	14	-4
Net Cash Flow	0	0	-0	5	8	-13
Free Cash Flow	-3	-2	3	-21	-5	-9
CFO/OP	-693%	-618%	148%	-893%	-157%	-246%

Free Cash Flow

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-5.00	-6.00	-10.00	-12.00	-8.00	-14.00	-16.00	-13.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	132	160	134	176	135	104	69	135
Inventory Days	112	66	70	89	34	72	86	88
Days Payable	142	148	105	145	123	139	172	243
Cash Conversion Cycle	103	78	99	120	46	38	-17	-20
Working Capital Days	3	6	44	47	37	108	80	137
ROCE %		8%	5%	3%	17%	9%	7%	7%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Nov 2025
Promoters	66.56%	66.56%	57.19%	9.98%	9.98%	9.98%	9.98%	9.13%
Public	33.45%	33.43%	42.81%	90.02%	90.02%	90.01%	90.02%	90.87%
No. of Shareholders	1,110	992	1,078	1,807	2,652	1,997	1,742	1,741

Shareholding Pattern Chart

No. of Shareholders

Dipna Pharmachem Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	0.41	0.45	260.55	333.40	6.91
Diluted EPS (Rs.)	0.41	0.45	260.55	333.40	6.91
Cash EPS (Rs.)	0.40	0.45	0.77	335.17	8.97
Book Value[Excl.RevalReserv]/Share (Rs.)	16.01	15.60	20.35	496.74	163.34
Book Value[Incl.RevalReserv]/Share (Rs.)	16.01	15.60	20.35	496.74	163.34
Revenue From Operations / Share (Rs.)	51.95	68.34	83.48	20787.26	8857.11
PBDIT / Share (Rs.)	1.43	1.43	1.96	644.23	118.66
PBIT / Share (Rs.)	1.43	1.42	1.95	642.46	116.60
PBT / Share (Rs.)	0.59	0.59	1.15	449.80	15.71
Net Profit / Share (Rs.)	0.40	0.45	0.76	333.40	6.91
PBDIT Margin (%)	2.75	2.08	2.35	3.09	1.33
PBIT Margin (%)	2.75	2.07	2.33	3.09	1.31
PBT Margin (%)	1.13	0.86	1.38	2.16	0.17
Net Profit Margin (%)	0.77	0.66	0.91	1.60	0.07
Return on Networth / Equity (%)	2.53	2.89	3.74	67.11	4.23
Return on Capital Employeed (%)	7.25	6.82	6.06	44.39	9.58
Return On Assets (%)	0.73	0.81	1.17	3.22	0.09
Long Term Debt / Equity (X)	0.23	0.33	0.58	1.91	6.44
Total Debt / Equity (X)	0.44	0.51	0.65	5.86	21.74
Asset Turnover Ratio (%)	0.94	1.56	1.76	2.38	1.43
Current Ratio (X)	1.56	1.60	1.99	1.16	1.21
Quick Ratio (X)	1.23	1.15	1.50	0.95	0.85
Inventory Turnover Ratio (X)	3.85	5.84	0.00	10.03	4.90
Interest Coverage Ratio (X)	1.71	1.72	2.46	3.34	1.18
Interest Coverage Ratio (Post Tax) (X)	1.48	1.54	1.95	2.73	1.07
Enterprise Value (Cr.)	51.18	28.22	25.24	0.00	0.00
EV / Net Operating Revenue (X)	0.40	0.17	0.25	0.00	0.00
EV / EBITDA (X)	14.85	8.22	10.74	0.00	0.00
MarketCap / Net Operating Revenue (X)	0.27	0.13	0.15	0.00	0.00
Price / BV (X)	0.89	0.60	0.61	0.00	0.00
Price / Net Operating Revenue (X)	0.27	0.13	0.15	0.00	0.00
EarningsYield	0.02	0.04	0.06	0.00	0.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Dipna Pharmachem Ltd. is a Public Limited Listed company incorporated on 19/07/2011 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24100GJ2011PLC066400 and registration number is 066400. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 124.92 Cr. and Equity Capital is Rs. 24.05 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	A/211, Siddhi Vinayak Complex, Ahmedabad Gujarat 380055	Contact not found

Management
Name	Position Held
Mr. Keyur Dipakkumar Shah	Managing Director
Ms. Dipna Keyur Shah	Non Executive Director
Mr. Nirav Soni	Non Executive Director
Mr. Nandish Shaileshbhai Jani	Independent Director
Mr. Parin Bhavsar	Independent Director

FAQ

What is the intrinsic value of Dipna Pharmachem Ltd and is it undervalued?

As of 21 April 2026, Dipna Pharmachem Ltd's intrinsic value is ₹13.18, which is 42.49% higher than the current market price of ₹9.25, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (2.55 %), book value (₹24.5), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Dipna Pharmachem Ltd?

Dipna Pharmachem Ltd is trading at ₹9.25 as of 21 April 2026, with a FY2026-2027 high of ₹26.3 and low of ₹7.45. The stock is currently near its 52-week low. Market cap stands at ₹24.3 Cr..

How does Dipna Pharmachem Ltd's P/E ratio compare to its industry?

Dipna Pharmachem Ltd has a P/E ratio of 11.9, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Dipna Pharmachem Ltd financially healthy?

Key indicators for Dipna Pharmachem Ltd: ROCE of 6.64 % is on the lower side compared to the industry average of 16.35%; ROE of 2.55 % is below ideal levels (industry average: 15.16%). Dividend yield is 0.00 %.

Is Dipna Pharmachem Ltd profitable and how is the profit trend?

Dipna Pharmachem Ltd reported a net profit of ₹1 Cr in Mar 2025 on revenue of ₹125 Cr. Compared to ₹1 Cr in Mar 2022, the net profit shows a mixed trend.

Does Dipna Pharmachem Ltd pay dividends?

Dipna Pharmachem Ltd has a dividend yield of 0.00 % at the current price of ₹9.25. The company is currently not paying meaningful dividends.